ProfileGDS4718 / 221524_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 71% 84% 68% 72% 74% 70% 68% 70% 71% 70% 78% 67% 69% 71% 72% 69% 73% 70% 89% 68% 70% 71% 71% 72% 65% 67% 69% 63% 65% 58% 77% 70% 67% 80% 87% 65% 78% 73% 92% 74% 73% 83% 74% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3767964
GSM549102patient 115, normal, homogenized [OPG study]6.924571
GSM549104patient 119, normal, homogenized [OPG study]8.3841384
GSM549108patient 138, normal, homogenized [OPG study]6.6685868
GSM549119patient 077, normal, homogenized [OPG study]7.0268572
GSM549133patient 032, cancer, homogenized [OPG study]7.3124374
GSM549139patient 042, cancer, homogenized [OPG study]6.8868170
GSM549099patient 107, normal, homogenized [OPG study]6.6964568
GSM549109patient 139, normal, homogenized [OPG study]6.8691470
GSM549110patient 046, normal, homogenized [OPG study]6.9067671
GSM549114patient 063, normal, homogenized [OPG study]6.8964670
GSM549122patient 082, normal, homogenized [OPG study]7.6494778
GSM549134patient 033, cancer, homogenized [OPG study]6.6544467
GSM549136patient 036, cancer, homogenized [OPG study]6.7952269
GSM549140patient 044, cancer, homogenized [OPG study]6.9902571
GSM549111patient 047, normal, homogenized [OPG study]7.1156372
GSM549113patient 057, normal, homogenized [OPG study]6.7972969
GSM549132patient 031, cancer, homogenized [OPG study]7.1186873
GSM549137patient 038, cancer, homogenized [OPG study]6.8781470
GSM549142patient 047, cancer, homogenized [OPG study]8.6114189
GSM549100patient 110, normal, homogenized [OPG study]6.6516568
GSM549107patient 135, normal, homogenized [OPG study]6.8410770
GSM549115patient 068, normal, homogenized [OPG study]7.004771
GSM549116patient 072, normal, homogenized [OPG study]6.9822171
GSM549120patient 078, normal, homogenized [OPG study]7.0229472
GSM549131patient 030, cancer, homogenized [OPG study]6.4697865
GSM549118patient 074, normal, homogenized [OPG study]6.6191567
GSM549129patient 027, cancer, homogenized [OPG study]6.8396569
GSM549123patient 088, normal, homogenized [OPG study]6.333663
GSM549124patient 006, cancer, homogenized [OPG study]6.479765
GSM549126patient 015, cancer, homogenized [OPG study]5.9792958
GSM549128patient 025, cancer, homogenized [OPG study]7.5999277
GSM549103patient 117, normal, homogenized [OPG study]6.8198370
GSM549117patient 073, normal, homogenized [OPG study]6.6118467
GSM549138patient 041, cancer, homogenized [OPG study]7.9121380
GSM549141patient 045, cancer, homogenized [OPG study]8.8824887
GSM549130patient 028, cancer, homogenized [OPG study]6.4374865
GSM549101patient 111, normal, homogenized [OPG study]7.6005378
GSM549105patient 128, normal, homogenized [OPG study]7.1412573
GSM549106patient 134, normal, homogenized [OPG study]9.669492
GSM549112patient 048, normal, homogenized [OPG study]7.1902774
GSM549125patient 011, cancer, homogenized [OPG study]7.1028873
GSM549127patient 024, cancer, homogenized [OPG study]8.2037483
GSM549135patient 035, cancer, homogenized [OPG study]7.2923574